Replacing Steroids in Transplant-Ineligible Multiple Myeloma: The Phase 2 Isatuximab-Bortezomib-Lenalidomide-Dexamethasone Rest Study

被引：0

作者：

Askeland, Frida Bugge Bugge ^{[1
,2
]}

Haukas, Einar ^{[3
]}

Slordahl, Tobias S. S. ^{[4
]}

Klostergaard, Anja ^{[5
]}

Alexandersen, Tatjana ^{[1
]}

Lysen, Anna ^{[6
]}

Abdollahi, Pegah ^{[1
]}

Hermansen, Emil ^{[7
]}

Schjesvold, Fredrik ^{[1
]}

机构：

[1] Oslo Univ Hosp, Oslo Myeloma Ctr, Oslo, Norway

[2] Univ Oslo, Inst Clin Med, Oslo, Norway

[3] Stavanger Univ Hosp, Dept Hematol & Oncol, Stavanger, Norway

[4] St Olavs Univ Hosp, Dept Hematol, Trondheim, Norway

[5] Aarhus Univ Hosp, Dept Hematol, Aarhus, Denmark

[6] Oslo Univ Hosp, OSlo Myeloma Ctr, Dept Hematol, Oslo, Norway

[7] Copenhagen Univ Hosp, Rigshosp, Dept Hematol, Copenhagen, Denmark

来源：

关键词：

D O I：

10.1182/blood-2024-193864

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：4730 / 4731

页数：2